Low ‐dose bortezomib and dexamethasone as primary therapy in elderly patients with Waldenstrӧm macroglobulinemia

ConclusionsOur findings show that lBD is an effective and tolerable treatment regimen for elderly patients with WM.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - August 12, 2017 Category: Hematology Authors: Ya ‐Ping Zhang, Xi Yang, Zeng‐Hua Lin, Xin‐Feng Wang, Xin Cao, Xue‐Fen You, Hong‐Ming Huang, Wen‐Yu Shi, Hong Liu Tags: Original Article Source Type: research